Cargando…
Contactin 1 modulates pegylated arginase resistance in small cell lung cancer through induction of epithelial–mesenchymal transition
Drug resistance is a major hurdle in the treatment of small cell lung cancer (SCLC). Previously we demonstrated the potential anticancer effect of pegylated arginase BCT-100 in SCLC cell lines and xenograft models. To facilitate future clinical application of BCT-100 in SCLC treatment, we elucidated...
Autores principales: | Xu, Shi, Lam, Sze-Kwan, Cheng, Paul Ning-Man, Ho, James Chung-Man |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6700313/ https://www.ncbi.nlm.nih.gov/pubmed/31427725 http://dx.doi.org/10.1038/s41598-019-48476-8 |
Ejemplares similares
-
Endogenous arginase 2 as a potential biomarker for PEGylated arginase 1 treatment in xenograft models of squamous cell lung carcinoma
por: Lam, Sze-Kwan, et al.
Publicado: (2019) -
Growth suppressive effect of pegylated arginase in malignant pleural mesothelioma xenografts
por: Lam, Sze-Kwan, et al.
Publicado: (2017) -
Inhibition of ornithine decarboxylase 1 facilitates pegylated arginase treatment in lung adenocarcinoma xenograft models
por: Lam, Sze-Kwan, et al.
Publicado: (2018) -
Recombinant human arginase induces apoptosis through oxidative stress and cell cycle arrest in small cell lung cancer
por: Xu, Shi, et al.
Publicado: (2018) -
Pegylated Recombinant Human Arginase 1 Induces Autophagy and Apoptosis via the ROS-Activated AKT/mTOR Pathway in Bladder Cancer Cells
por: Zhao, Zhuyun, et al.
Publicado: (2021)